The Partnership to Fight Infectious Disease (Pfid)
Advocacy for issues related to infectious like AMR
Based in DC
🤖
AI Overview
With $750K in lobbying spend across 17 quarterly filings, The Partnership to Fight Infectious Disease (Pfid) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
$750K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $120K |
| 2023 | $210K |
| 2024 | $240K |
| 2025 | $180K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •The need for Congress to pass financial incentives for the purpose of encouraging the development of new and novel antibiotics as well as other steps to address AMR.
- •The need for Congress to pass new financial incentives for the purpose of encouraging new and novel antibiotic development as well as other steps to combat Antimicrobial Resistance (AMR)
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.